North America Deep Brain Stimulation Devices Market Size & Outlook
North America deep brain stimulation devices market, 2018-2030 (US$M)
Related Markets
North America deep brain stimulation devices market highlights
- The North America deep brain stimulation devices market generated a revenue of USD 710.0 million in 2024.
- The market is expected to grow at a CAGR of 9.5% from 2025 to 2030.
- In terms of segment, dystonia was the largest revenue generating application in 2024.
- Epilepsy is the most lucrative application segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2025 to 2030.
North America data book summary
| Market revenue in 2024 | USD 710.0 million |
| Market revenue in 2030 | USD 1,212.4 million |
| Growth rate | 9.5% (CAGR from 2025 to 2030) |
| Largest segment | Dystonia |
| Fastest growing segment | Epilepsy |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pain Management, Epilepsy, Essential Tremor, Obsessive Compulsive Disorder (OCD), Parkinsons Disease, Depression, Dystonia |
| Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Other key industry trends
- In terms of revenue, North America region accounted for 50.6% of the global deep brain stimulation devices market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 366.5 million by 2030.
Dystonia was the largest segment with a revenue share of 69.04% in 2024. Horizon Databook has segmented the North America deep brain stimulation devices market based on pain management, epilepsy, essential tremor, obsessive compulsive disorder (ocd), parkinsons disease, depression, dystonia covering the revenue growth of each sub-segment from 2018 to 2030.
The rising prevalence of movement and psychiatric disorders coupled with increasing geriatric population in the region. For instance, according to Parkinson's Foundation (PF), symptoms of Parkinson's Disease (PD) are common at an average age of 60.
The geriatric population is highly susceptible to these disorders. In addition, increase in government funding and initiatives for raising awareness about movement disorders is expected to drive the demand for deep brain stimulation devices in the region.
This approval will expand treatment options for more than one million patients suffering from seizures and do not respond to medication in the U.S. These factors are expected to boost the demand for deep brain stimulation devices in this region.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Deep Brain Stimulation Devices Market Scope
Deep Brain Stimulation Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America deep brain stimulation devices market size, by country, 2018-2030 (US$M)
North America Deep Brain Stimulation Devices Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
